AllianceBernstein
GBT

AllianceBernstein’s Global Blood Therapeutics, Inc. GBT Stock Holding History

AllianceBernstein’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-100,000
Closed -$2.73M – 3140
2017
Q2 		$2.73M Buy
+100,000
New +$2.98M ﹤0.01% 1618

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

AllianceBernstein's GBT Position: Q4 2022 in Review

AllianceBernstein sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 399,290 shares — an estimated $27.2M sold.

AllianceBernstein first reported a position in GBT in Q3 2015 and held it in 28 quarters. The position peaked at $27.2M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • AllianceBernstein reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • AllianceBernstein sold 399,290 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $27.2M.
  • AllianceBernstein first reported a position in Global Blood Therapeutics, Inc. in Q3 2015 and held it in 28 quarters.
  • AllianceBernstein's Global Blood Therapeutics, Inc. position peaked at $27.2M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on AllianceBernstein's 13F filing for Q4 2022, filed 15 Feb 2023.